Toxicity and Safety Concerns in Orlistat Therapy for Obesity: A Critical Evaluation
Asian Journal of Biomedical and Pharmaceutical Sciences · 2015
DOI: 10.15272/ajbps.v5i47.725 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Journal of Biomedical and Pharmaceutical Sciences, 2015. Verfasst von Nwobodo N. N.. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Abstract (Originalsprache)
Orlistat is a selective inhibitor of gastric and pancreatic lipase indicated for the treatment of obesity. It is also known to significantly reduce risk of associated co-morbidities such as heart attack, type-2 diabetes mellitus, hypertension and stroke. Recent reports have raised concerns on the possible occurrence of serious adverse effects with prolonged use. Orlistat has been shown to inhibit carboxylesterase-2, a major detoxification enzyme, predisposing to severe liver, pancreatic and kidney damage. Orlistat alters the pharmacodynamic response of some drugs when co-administered leading to severe toxicity and reduced efficacy. Safety is a major concern considering the widespread use of this drug both as a prescription and over-the-counter medication. There is need for large-scale observation studies on orlistat use to generate appropriate data that will guide the regulatory agencies in taking relevant decision on continued use of orlistat as anti-obesity drug.
Zitieren
APA
N., N. N. (2015). Toxicity and Safety Concerns in Orlistat Therapy for Obesity: A Critical Evaluation. Asian Journal of Biomedical and Pharmaceutical Sciences. https://doi.org/10.15272/ajbps.v5i47.725
Vancouver
N. NN. Toxicity and Safety Concerns in Orlistat Therapy for Obesity: A Critical Evaluation. Asian Journal of Biomedical and Pharmaceutical Sciences. 2015. doi:10.15272/ajbps.v5i47.725
BibTeX
@article{N2015,
author = {N., Nwobodo N.},
title = {Toxicity and Safety Concerns in Orlistat Therapy for Obesity: A Critical Evaluation},
journal = {Asian Journal of Biomedical and Pharmaceutical Sciences},
year = {2015},
doi = {10.15272/ajbps.v5i47.725}
}
EUVIMED